Yabao Pharmaceutical Co., Ltd. Beijing drugs

1 result
  • sorafenib

    (sorafenib)
    Yabao Pharmaceutical Co., Ltd. Beijing
    Sorafenib tablets are indicated for patients with unresectable hepatocellular carcinoma (HCC) and those with locally recurrent or metastatic, progressive differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment.